Kymera Therapeutics KYMR Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Kymera Therapeutics’s reported figures.
The official record: Kymera Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kymera Therapeutics's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Kymera Therapeutics's invested capital?
- Kymera Therapeutics (KYMR) reported invested capital of $1.48B in Q1 2026.
- How has Kymera Therapeutics's invested capital changed year-over-year?
- Kymera Therapeutics's invested capital increased by 88.4% year-over-year, from $784.16M to $1.48B.
- What is the long-term trend for Kymera Therapeutics's invested capital?
- Over 5 years (2020 to 2025), Kymera Therapeutics's invested capital has grown at a 36.9% compound annual growth rate (CAGR), from $271.57M to $1.31B.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).